Evidence map›Paper›PMID 40960498›Full record

ArticleArchives of toxicology2026

Oxidative stress-driven disease-associated microglia (DAM)-like polarization in human microglia (HMC3) cells exposed to small-size silver nanoparticles in a transwell co-culture system with neurons (cholinergic differentiated SH-SY5Y) cells in vitro.

Bartosz Skóra, Konrad A Szychowski

Abstract read
In one paragraph

Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bartosz SkóraDepartment of Biotechnology and Cell Biology, Medical College, University of Information Technology and Management in Rzeszow, St. Sucharskiego 2, 35-225, Rzeszow, Poland. bskora@wsiz.edu.pl.ORCID 0000-0001-7833-9985
Konrad A SzychowskiDepartment of Biotechnology and Cell Biology, Medical College, University of Information Technology and Management in Rzeszow, St. Sucharskiego 2, 35-225, Rzeszow, Poland.ORCID 0000-0003-2207-1160

Funding

National Science Center, Poland 2024/08/X/NZ3/00463
6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) are well-established pro-oxidative and pro-inflammatory factors, with the strongest effects observed in smaller NPs. This is particularly important due to the increasing accumulation of AgNPs in the environment and the human food chain in recent years. This accumulation has been correlated with an increased number of neurodegenerative diseases, in which microglia-driven inflammation plays a pivotal role. Importantly, the disease-associated microglia (DAM) phenotype has gained special attention. Therefore, this study aimed to determine the role of small-size AgNPs in inducing a DAM-like phenotype in a transwell co-culture model of human microglia (HMC3) and neurons (differentiated SH-SY5Y) in vitro. Our results demonstrated time- and dose-dependent cytotoxicity of small-size AgNPs in both tested cell models. Moreover, in the transwell co-culture system of HMC3 and differentiated SH-SY5Y cells, exposure to AgNPs led to ROS-dependent inflammation, associated with TLR4 and NF-κB activation, subsequently upregulating DAM-related proteins (e.g., ICAM1, ITGAX, ApoE, and B2M). A time-dependent increase in

Indexed as

Metal NanoparticlesMicrogliaNeuronsOxidative StressSilverCell DifferentiationCell Line, TumorCell SurvivalCoculture TechniquesHumansParticle SizeReactive Oxygen SpeciesReactive Oxygen SpeciesSilverDisease-associated microgliaInflammationNeurodegenerationNeuronsSilver nanoparticles

Identifiers

PMID40960498
PMCPMC12858520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.